co.don Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
co.don Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, co.don's Price has grown, rising from 0.00€ to 0.00€ – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach 0.00€ – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BNTX Stock Forecast | BioNTech | Outperform |
12
|
$87.21 | Buy/Sell | $123.75 | 15.28% |
| MOR Stock Forecast | MorphoSys | Outperform |
6
|
67.85€ | Buy/Sell | 28.78€ | 0.22% |
| EVT Stock Forecast | Evotec | Outperform |
14
|
9.24€ | Buy/Sell | 37.33€ | 175.97% |
| BIO3 Stock Forecast | Biotest | Hold |
9
|
28.70€ | Buy/Sell | 37.00€ | 28.92% |
| IMTX Stock Forecast | Immatics N.V. | Buy |
4
|
$10.01 | Buy/Sell | $19.83 | 99.80% |
co.don Revenue Forecast for 2023 - 2025 - 2030
In the last year, co.don's Revenue has grown, rising from 6.23€M to 9.80€M – a growth of 57.30%. In the next year, 0 analysts estimate that co.don's Revenue will decrease by 36.43%, reaching 6.23€M. According to professional forecasts, in 2030, co.don's Revenue will decrease by 17.22%, reaching 8.11€M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FYB Stock Forecast | Formycon | Buy |
11
|
39.95€ | Buy/Sell | 106.60€ | 127.78% |
| CVAC Stock Forecast | CureVac N.V. | Outperform |
6
|
$2.33 | Buy/Sell | $12.92 | 488.41% |
| HPHA Stock Forecast | Heidelberg Pharma | Buy |
11
|
2.97€ | Buy/Sell | 6.70€ | 280.47% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VSC Stock Forecast | 4SC | - |
4
|
8.86€ | Buy/Sell | 17.10€ | -100.00% |
| V3V Stock Forecast | VITA 34 | Hold |
10
|
5.15€ | Buy/Sell | 5.21€ | 2.91% |
| IFRX Stock Forecast | InflaRx N.V. | Outperform |
4
|
$1.33 | Buy/Sell | $9.44 | 420.30% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AFMD Stock Forecast | Affimed N.V. | Buy |
7
|
$5.03 | Buy/Sell | $5.25 | 221.07% |
| BNN Stock Forecast | BRAIN Biotech | Buy |
8
|
2.88€ | Buy/Sell | 11.23€ | 330.56% |
| MDG1 Stock Forecast | Medigene | Buy |
6
|
1.51€ | Buy/Sell | 2.68€ | 77.48% |
co.don EBITDA Forecast for 2023 - 2025 - 2030
In the last year, co.don's EBITDA has decreased by 12.71%, going from -8.81€M to -7.69€M. For the next year, analysts predict that EBITDA will reach -8.81€M – an increase of 14.56%. Over the next nine years, experts believe that co.don's EBITDA will grow at a rate of 10.33%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 2INV Stock Forecast | 2invest | - |
0
|
7.50€ | Buy/Sell | 29.70€ | -100.00% |
| VVY Stock Forecast | Vivoryon Therapeutics N.V. | Outperform |
4
|
0.80€ | Buy/Sell | 34.38€ | 7400.00% |
| ALTME Stock Forecast | TME Pharma N.V. | - |
-23
|
0.25€ | Buy/Sell | 3.52€ | -100.00% |
co.don EBIT Forecast for 2023 - 2025 - 2030
In the last year, co.don's EBIT has decreased from -9.14€M to -8.43€M – a 7.77% drop. In the next year, analysts predict that EBIT will jump to -9.14€M – up 8.42% from the current level. Looking ahead to nine years, experts forecast that EBIT will grow by 5.79%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DBI Stock Forecast | Deutsche Biotech Innovativ | - |
6
|
1.35€ | Buy/Sell | 43.60€ | -100.00% |
| T5O Stock Forecast | bioXXmed | - |
4
|
0.49€ | Buy/Sell | 3.10€ | -100.00% |
| MGNK Stock Forecast | Mologen | - |
0
|
0.08€ | Buy/Sell | 0.00€ | -100.00% |
co.don EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, co.don's EPS has grown, rising from -0.86€ to 0.00€ – a growth of 100.00%. In the next year, analysts believe that EPS will reach 0.00€ – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SBH Stock Forecast | Sangui Biotech International | - |
0
|
0.00€ | Buy/Sell | 0.00€ | 0.00% |
| PA8 Stock Forecast | Paion | Hold |
6
|
0.03€ | Buy/Sell | 9.85€ | -100.00% |
| MF6 Stock Forecast | MagForce | - |
7
|
0.00€ | Buy/Sell | 11.86€ | 0.00% |
.jpg)